Feasibility of using microbiology diagnostic tests of moderate or high complexity at the point-of-care in a delivery suite

Journal of Obstetrics and Gynaecology

Volumn 32, Issue 5, 2012, Pages 458-460

  Gray, J W ^a   Milner, P J ^a   Edwards, E H ^a   Daniels, J P ^a   Khan, K S ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Group B streptococcus; Microbiology; Point of care testing; Test complexity

Indexed keywords

ARTICLE; DELIVERY ROOM; DIAGNOSTIC TEST; FEASIBILITY STUDY; FEMALE; HUMAN; IMMUNOASSAY; LABOR; MAJOR CLINICAL STUDY; MEDICAL INSTRUMENTATION; MICROBIOLOGY; MIDWIFE; POINT OF CARE TESTING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STREPTOCOCCUS AGALACTIAE; TRAINING; VAGINA;

DELIVERY, OBSTETRIC; FEMALE; HUMANS; LABOR, OBSTETRIC; POINT-OF-CARE SYSTEMS; PREGNANCY; RECTUM; SENSITIVITY AND SPECIFICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA;

EID: 84861817741     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2012.673034     Document Type: Article

References (19)

1. Anon. 2004. Point-of-care testing (near-patient testing). Guidance on the involvement of the clinical laboratory. London: Institute of Biomedical Science.
2. Anon. 2008. False-positive oral fl uid rapid HIV tests-New York City, 2005-2008. MMWR. Morbidity and Mortality Weekly Report 57:1-5.
3. Brenwald NP, Baker N, Oppenheim B. 2010. Feasibility study of a real-time PCR test for methicillin-resistant Staphylococcus aureus in a point-ofcare setting. Journal of Hospital Infection 74:245-249.
4. Cramb R. 2004. Guidelines on point-of-care testing. London: Th e Royal College of Pathologists.
5. Daniels J, Gray J, Pattison H, Roberts T, Edwards E, Milner P et al. 2009. Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-eff ectiveness. Health Technology Assessment 13:1-154.
6. Device Bulletin. 2003. Management and use of IVD point-of-care test devices. MDA DB2002(03). London: Medical Devices Agency.
7. Griffi ths MW. 1997. Rapid microbiological methods with hazard analysis critical control point. Journal of AOAC International 80:1143-1150.
8. Haglund S, Trans ö B, Persson LG, Zafi rova T, Grodzinsky E. 2009. Fast laboratory test results alone cannot deliver the benefi ts of near patient testing: a follow-up study aft er 3 years of extended laboratory service at a primary health care centre. Journal of Evaluation in Clinical Practice 15:227-33.
9. Harbarth S, Masuet-Aumatell C, Schrenzel J, Francois P, Akakpo C, Renzi G et al. 2006. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Critical Care 10:R25.
10. Hatchette TF, Bastien N, Berry J, Booth TF, Chernesky M, Couillard M et al. 2009. Th e limitations of point-of-care testing for pandemic infl uenza: what clinicians and public health professionals need to know. Canadian Journal of Public Health 100:204-7.
11. Information Centre for Health and Social Care. 2005. Sickness absence rates of NHS staff in 2004. London: Department of Health.
12. Kiechle FL, Holland CA. 2009. Point-of-care testing and molecular diagnostics: miniaturization required. Clinics in Laboratory Medicine 29:555-60.
13. Kim JY, Lewandrowski K. 2009. Point-of-care testing informatics. Clinics in Laboratory Medicine 29:449-61.
14. Lee-Lewandrowski E, Lewandrowski K. 2009. Perspectives on cost and outcomes for point-of-care testing. Clinics in Laboratory Medicine 29:479-89.
15. Martin CL. 2008. Quality control issues in point-of-care testing. Clinical Biochemist Reviews 29:S79-S82.
16. NHS Institute for Innovation and Improvement. Workforce: Acute Trusts. Available at: www.productivity.nhs.uk (Accessed January 2010).
17. Price CP. 2001. Point-of-care testing. Impact on medical outcomes. Clinics in Laboratory Medicine 21:285-303.
18. Robertson BH, Nicholson JK. 2005. New microbiology tools for public health and their implications. Annual Review of Public Health 26: 281-302.
19. US Food and Drug Administration. CLIA categorization criteria. Available at: www.fda.gov/cdrh/clia/categorization.html (Accessed January 2010).